| Literature DB >> 25793427 |
Jie Yang1,2, Hui-Lin Zhao3,4,5, Bai-Lu Tang6,7, Xiu-Lan Chen8,9, Hai-Nan Su10,11, Xi-Ying Zhang12,13, Xiao-Yan Song14,15, Bai-Cheng Zhou16,17, Bin-Bin Xie18,19, Anthony S Weiss20, Yu-Zhong Zhang21,22.
Abstract
Elastases have been widely studied because of their important uses as medicine and meat tenderizers. However, there are relatively few studies on marine elastases. Myroilysin, secreted by Myroides profundi D25 from deep-sea sediment, is a novel elastase. In this study, we examined the elastin degradation mechanism of myroilysin. When mixed with insoluble bovine elastin, myroilysin bound hydrophobically, suggesting that this elastase may interact with the hydrophobic domains of elastin. Consistent with this, analysis of the cleavage pattern of myroilysin on bovine elastin and recombinant tropoelastin revealed that myroilysin preferentially cleaves peptide bonds with hydrophobic residues at the P1 and/or P1' positions. Scanning electron microscopy (SEM) of cross-linked recombinant tropoelastin degraded by myroilysin showed preferential damages of spherules over cross-links, as expected for a hydrophobic preference. The degradation process of myroilysin on bovine elastin fibres was followed by light microscopy and SEM, revealing that degradation begins with the formation of crevices and cavities at the fibre surface, with these openings increasing in number and size until the fibre breaks into small pieces, which are subsequently fragmented. Our results are helpful for developing biotechnological applications for myroilysin.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25793427 PMCID: PMC4377995 DOI: 10.3390/md13031481
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Binding of myroilysin to insoluble elastin fibres through hydrophobic interaction. (A) SDS-PAGE analysis of the ability of myroilysin to bind to insoluble elastin-orcein. Bovine serum albumin in place of myroilysin was used as a negative control. The bound and unbound fractions were analysed by 12.5% SDS-PAGE. The numbers at the bottom of the gel are the densitometric ratios of each band compared with that of the control band. (B) The elastin-degrading activity of myroilysin bound to insoluble elastin-orcein. The total activity of 0.25 mL myroilysin solution was taken as 100%. The activity of the mixture of 5 mg elastin-orcein with buffer served as a control. The data are from three experimental repeats (mean ± S.D.). (C) Effects of NaCl and nonionic detergents on the binding of myroilysin to insoluble elastin-orcein.
Figure 2(A) Domain map of bovine tropoelastin containing all possible exons. The hydrophilic cross-linking domains are further divided into KP cross-linking domains, with lysine pairs separated by one or more proline residues, and KA cross-linking domains, with lysine pairs separated by alanine residues. Domain 36 is assigned differently because of its unique structural features [19]. (B) Cleavage sites of myroilysin in bovine tropoelastin (SwissProt Accession Number P04985-1). Each dashed arrow above the sequence indicates a domain encoded by an individual exon. The cleavage sites are marked by vertical arrows. The cleavage sites were determined based on the sequences of peptides from bovine elastin released by myroilysin, as shown in Supplementary Table S1. The sequences covered by the determined peptides are underlined with grey solid lines.
Myroilysin specificity for bovine elastin a.
| P4 | P3 | P2 | P1 | P1′ | P2′ | P3′ | P4′ | Occurrence Number | |
|---|---|---|---|---|---|---|---|---|---|
| G | 30.86 | 37.04 | 23.46 | 64.20 | 25.93 | 32.10 | 46.91 | 22.22 | 229 |
| V | 17.28 | 20.99 | 23.46 | 3.70 | 43.21 | 17.28 | 19.75 | 27.16 | 140 |
| P | 20.99 | 13.58 | 17.28 | 4.94 | 1.23 | 20.99 | 12.35 | 22.22 | 92 |
| A | 14.81 | 11.11 | 13.58 | 14.81 | 9.88 | 7.41 | 4.94 | 9.88 | 70 |
| L | 4.94 | 3.70 | 8.64 | 4.94 | 7.41 | 9.88 | 6.17 | 8.64 | 44 |
| Y | 1.23 | 1.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 |
| F | 1.23 | 1.23 | 2.47 | 2.47 | 3.70 | 4.94 | 3.70 | 2.47 | 18 |
| I | 2.47 | 1.23 | 2.47 | 0.00 | 3.70 | 2.47 | 0.00 | 2.47 | 12 |
| K | 3.70 | 3.70 | 1.23 | 0.00 | 0.00 | 0.00 | 1.23 | 1.23 | 9 |
| Q | 0.00 | 2.47 | 3.70 | 1.23 | 2.47 | 1.23 | 0.00 | 1.23 | 10 |
| T | 0.00 | 2.47 | 2.47 | 1.23 | 1.23 | 1.23 | 1.23 | 2.47 | 10 |
| R | 1.23 | 0.00 | 0.00 | 1.23 | 0.00 | 0.00 | 1.23 | 0.00 | 3 |
| S | 1.23 | 1.23 | 1.23 | 1.23 | 1.23 | 2.47 | 2.47 | 0.00 | 9 |
a Occurrence of different amino acids at the substrate positions P1–P4 and P1′–P4′, which refers to the preference for a particular amino acid at a given position. The last column shows the number of occurrences of each amino acid.
Figure 3In situ observation of the degradation of a bovine elastic fibre by myroilysin: (A) 0 min; (B) 5 min; (C) 10 min; (D) 15 min; (E) 20 min; (F) 25 min. Magnification is ×960. Bars: 5 μm.
Figure 4SEM of bovine elastin fibre degradation by myroilysin. A mixture of 0.2 mL myroilysin (0.05 mg/mL) with 5 mg bovine elastin fibres in 50 mM Tris-HCl buffer (pH 9.0) was incubated at 37 °C with continuous stirring. The same reaction system without myroilysin served as a control (A). At different time points of digestion ((B) 30 min; (C) 60 min; (D) 120 min), the elastin fibres were separated and washed twice with deionized water. After lyophilization, the samples were mounted on a metal grid and coated with 5 nm platinum prior to SEM at 5.0 kV. Bars: 2 μm.
Figure 5Degradation of recombinant tropoelastin cross-linking clusters by myroilysin. Tropoelastin was cross-linked with BS3 then incubated with myroilysin for: 0 min (A,E); 20 min (B,F); 60 min (C,G) and 150 min (D,H). E–H are the same samples as A–D, respectively, with higher magnification. Bars in A–D: 2μm. Bars in E–H: 300 nm.
Figure 6(A) Domain map of human tropoelastin containing all possible exons. The hydrophilic cross-linking domains are further divided into KP cross-linking domains, with lysine pairs separated by one or more proline residues, and KA cross-linking domains, with lysine pairs separated by alanine residues. Domain 36 is assigned differently because of its unique structural features [2]. (B) Cleavage sites of myroilysin in recombinant human tropoelastin. Each dashed arrow above the sequence indicates a domain encoded by an individual exon. The cleavage sites are marked by vertical arrows. The cleavage sites were determined based on the sequences of peptides from recombinant human tropoelastin released by myroilysin, as shown in Supplementary Table S2. The sequences covered by the determined peptides are underlined with grey solid lines.
Myroilysin specificity for recombinant human tropoelastin a.
| P4 | P3 | P2 | P1 | P1′ | P2′ | P3′ | P4′ | Occurrence Number | |
|---|---|---|---|---|---|---|---|---|---|
| G | 28.89 | 22.22 | 35.56 | 36.67 | 36.67 | 16.67 | 31.11 | 22.22 | 207 |
| V | 14.44 | 13.33 | 3.33 | 7.78 | 12.22 | 16.67 | 8.89 | 22.22 | 89 |
| P | 14.44 | 31.11 | 8.89 | 11.11 | 3.33 | 27.78 | 15.56 | 20.00 | 119 |
| A | 20.00 | 14.44 | 17.78 | 21.11 | 22.22 | 17.78 | 17.78 | 14.44 | 131 |
| L | 5.56 | 6.67 | 10.00 | 6.67 | 11.11 | 8.89 | 6.67 | 6.67 | 56 |
| Y | 3.33 | 0.00 | 7.78 | 2.22 | 1.11 | 1.11 | 3.33 | 0.00 | 17 |
| F | 3.33 | 2.22 | 5.56 | 4.44 | 1.11 | 0.00 | 1.11 | 1.11 | 17 |
| I | 1.11 | 1.11 | 3.33 | 0.00 | 5.56 | 3.33 | 1.11 | 2.22 | 16 |
| C | 0.00 | 0.00 | 0.00 | 0.00 | 1.11 | 1.11 | 1.11 | 1.11 | 4 |
| K | 3.33 | 5.56 | 3.33 | 7.78 | 3.33 | 3.33 | 7.78 | 5.56 | 36 |
| Q | 1.11 | 1.11 | 2.22 | 0.00 | 0.00 | 0.00 | 1.11 | 1.11 | 6 |
| T | 1.11 | 1.11 | 0.00 | 1.11 | 2.22 | 0.00 | 0.00 | 1.11 | 6 |
| R | 1.11 | 0.00 | 0.00 | 1.11 | 0.00 | 1.11 | 2.22 | 1.11 | 6 |
| S | 2.22 | 0.00 | 1.11 | 0.00 | 0.00 | 2.22 | 2.22 | 1.11 | 8 |
| E | 0.00 | 1.11 | 1.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 |
a Occurrence of different amino acids at the substrate positions P1–P4 and P1′–P4′, which refers to the preference for a particular amino acid at a given position. The last column shows the number of occurrences of each amino acid.